Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2008 Dec 13;50(4):1726–1733. doi: 10.1167/iovs.08-2718

FIGURE 4.

FIGURE 4

Venn diagrams of SWAP using the FT strategy and the SITA outcomes among the patients with GON (n = 286). Visual field abnormality is determined by: (A) ROC curve-derived PSD at 95% specificity, (B) ROC-derived PDP points triggered at <1% at 95% specificity, (C) machine-derived PSD at 95% (P < 5%), and (D) machine-derived PSD at 99.5% (P < 0.5%).